Epizyme, Inc.

CITADEL ADVISORS LLC

Report date

6/30/2022

Quarter

2022 Q2

Filed

8/15/2022

Shares

691,458

Value ($000)

1,016

Weight

0.0%

2019 Q4 - 2022 Q2 (11 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	8/15/2022	1,016	0.0%	691,458	6/30/2022
2022 Q1	5/16/2022	4,834	0.0%	4,204,066	3/31/2022
2021 Q4	2/14/2022	1,941	0.0%	776,335	12/31/2021
2021 Q3	11/15/2021	203	0.0%	39,650	9/30/2021
2021 Q2	8/16/2021	556	0.0%	66,849	6/30/2021
2021 Q1	5/21/2021	630	0.0%	72,296	3/31/2021
2020 Q4	2/16/2021	8,733	0.0%	804,168	12/31/2020
2020 Q3	11/16/2020	2,432	0.0%	203,863	9/30/2020
2020 Q2	8/14/2020	2,045	0.0%	127,337	6/30/2020
2020 Q1	5/15/2020	634	0.0%	40,915	3/31/2020
2019 Q4	2/14/2020	600	0.0%	24,395	12/31/2019